Literature DB >> 28224325

Comparison of Contrast-Enhanced CT and [18F]FDG PET/CT Analysis Using Kurtosis and Skewness in Patients with Primary Colorectal Cancer.

Franca Wagner1,2,3,4, Yahya Ali Hakami5, Geoffrey Warnock5,6, Gabriel Fischer7,8, Martin W Huellner5,6,9, Patrick Veit-Haibach5,6,10.   

Abstract

PURPOSE: Heterogeneity is a key feature of malignancy associated with adverse tumor biology. Texture analysis with different imaging modalities has been shown to reflect tumor heterogeneity. The current study analyzed and compared pre-treatment (contrast-enhanced) ceCT and positron emission tomography/computed tomography (PET/CT) tumor heterogeneity using the parameters skewness and kurtosis in patients with primary colorectal cancer with and without liver metastases. PROCEDURES: The histogram-derived texture parameters skewness and kurtosis were retrospectively analyzed obtained on PET/CT and ceCT images from 50 patients with histopathology proven primary colorectal cancer (32 patients without liver metastases and 18 with liver metastases). All patients underwent pretreatment ceCT and a 2-deoxy-2-[18F]Fluoro-D-glucose PET/CT of the whole body for initial staging before treatment. The following parameters were analyzed: (1) skewness ceCT and PET/CT combined, (2) skewness ceCT, (3) skewness PET/CT, (4) kurtosis ceCT and PET/CT combined, (5) kurtosis ceCT, and (6) kurtosis PET/CT. For each parameter, the following comparisons were analyzed: (A) colon tumors in 32 patients without liver metastasis versus colon tumors in 18 patients with liver metastasis, (B) colon tumors (all 50 patients, with and without liver metastases) versus 56 liver metastases of patients with metastatic disease to the liver, (C) colon tumors in 32 patients without liver metastasis versus 56 summed metastasis of the 18 patients with metastatic disease to the liver, and (D) colon tumors in 18 patients with liver metastasis versus summed 56 liver metastasis. Furthermore, ceCT parameters were compared to PET/CT parameters (separately for skewness and kurtosis), and the correlation of the clinical stage with skewness and kurtosis was analyzed.
RESULTS: Skewness and kurtosis were not statistically significantly different in primary colon cancer lesions between patients with or without liver metastases (p > 0.05). However, there were significant differences found between primary colon cancer and hepatic metastases (p < 0.05). Thus, skewness and kurtosis derived by ceCT and PET/CT showed significantly different heterogeneities between primary colon cancer lesions and hepatic metastases. The clinical stage was not associated with skewness or kurtosis (r = 0.06 and r = 0.05).
CONCLUSION: Texture analysis with relatively simple first-order parameters skewness and kurtosis on ceCT and on PET/CT was able to differentiate between primary colon cancer and hepatic metastases. No differentiation was observed between primary colon tumor lesions in patients with or without hepatic metastases. Overall, skewness and kurtosis measured with ceCT and PET/CT seem to have complementary roles in the evaluation of heterogeneity.

Entities:  

Keywords:  Colon cancer; Hepatic metastases; Kurtosis; PET/CT; Skewness; Texture analysis; ceCT

Mesh:

Substances:

Year:  2017        PMID: 28224325     DOI: 10.1007/s11307-017-1066-x

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  44 in total

1.  In search of biologic correlates for liver texture on portal-phase CT.

Authors:  Balaji Ganeshan; Kenneth A Miles; Rupert C D Young; Chris R Chatwin
Journal:  Acad Radiol       Date:  2007-09       Impact factor: 3.173

2.  On some misconceptions about tumor heterogeneity quantification.

Authors:  Frank J Brooks
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-30       Impact factor: 9.236

3.  Non-small cell lung cancer: histopathologic correlates for texture parameters at CT.

Authors:  Balaji Ganeshan; Vicky Goh; Henry C Mandeville; Quan Sing Ng; Peter J Hoskin; Kenneth A Miles
Journal:  Radiology       Date:  2012-11-20       Impact factor: 11.105

4.  Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival.

Authors:  Balaji Ganeshan; Elleny Panayiotou; Kate Burnand; Sabina Dizdarevic; Ken Miles
Journal:  Eur Radiol       Date:  2011-11-17       Impact factor: 5.315

5.  Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival.

Authors:  Francesca Ng; Balaji Ganeshan; Robert Kozarski; Kenneth A Miles; Vicky Goh
Journal:  Radiology       Date:  2012-11-14       Impact factor: 11.105

6.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

7.  Increased metabolic activity of indolent liver metastases after resection of a primary colorectal tumor.

Authors:  Marian G W Scheer; Thamar H Stollman; Wouter V Vogel; Otto C Boerman; Wim J G Oyen; Theo J M Ruers
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis.

Authors:  Yong Sub Song; Seung Hong Choi; Chul-Kee Park; Kyung Sik Yi; Woong Jae Lee; Tae Jin Yun; Tae Min Kim; Se-Hoon Lee; Ji-Hoon Kim; Chul-Ho Sohn; Sung-Hye Park; Il Han Kim; Geon-Ho Jahng; Kee-Hyun Chang
Journal:  Korean J Radiol       Date:  2013-07-17       Impact factor: 3.500

10.  Quantitative CT variables enabling response prediction in neoadjuvant therapy with EGFR-TKIs: are they different from those in neoadjuvant concurrent chemoradiotherapy?

Authors:  Yousun Chong; Jae-Hun Kim; Ho Yun Lee; Yong Chan Ahn; Kyung Soo Lee; Myung-Ju Ahn; Jhingook Kim; Young Mog Shim; Joungho Han; Yoon-La Choi
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more
  11 in total

1.  Radiomics based on multisequence magnetic resonance imaging for the preoperative prediction of peritoneal metastasis in ovarian cancer.

Authors:  Xiao-Li Song; Jia-Liang Ren; Ting-Yu Yao; Dan Zhao; Jinliang Niu
Journal:  Eur Radiol       Date:  2021-05-04       Impact factor: 5.315

Review 2.  Radiomics in Oncological PET/CT: Clinical Applications.

Authors:  Jeong Won Lee; Sang Mi Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-10-20

Review 3.  Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT.

Authors:  Robert J O'Shea; Chris Rookyard; Sam Withey; Gary J R Cook; Sophia Tsoka; Vicky Goh
Journal:  Insights Imaging       Date:  2022-06-17

4.  Imaging and monitoring HER2 expression in breast cancer during trastuzumab therapy with a peptide probe 99mTc-HYNIC-H10F.

Authors:  Yue Wu; Liqiang Li; Zihua Wang; Jiyun Shi; Zhiyuan Hu; Shi Gao; Weibing Miao; Qingjie Ma; Chengyan Dong; Fan Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-13       Impact factor: 9.236

5.  Comparison of DWI and 18F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis.

Authors:  Mingxu Luo; Hongmei Song; Gang Liu; Yikai Lin; Lintao Luo; Xin Zhou; Bo Chen
Journal:  Oncotarget       Date:  2017-09-19

6.  Three-Dimensional CT Texture Analysis to Differentiate Colorectal Signet-Ring Cell Carcinoma and Adenocarcinoma.

Authors:  Yali Yue; Feixiang Hu; Tingdan Hu; Yiqun Sun; Tong Tong; Yajia Gu
Journal:  Cancer Manag Res       Date:  2019-12-13       Impact factor: 3.989

7.  Development and Validation of a 18F-FDG PET-Based Radiomic Model for Evaluating Hypermetabolic Mediastinal-Hilar Lymph Nodes in Non-Small-Cell Lung Cancer.

Authors:  Ming-Li Ouyang; Yi-Ran Wang; Qing-Shan Deng; Ye-Fei Zhu; Zhen-Hua Zhao; Ling Wang; Liang-Xing Wang; Kun Tang
Journal:  Front Oncol       Date:  2021-09-08       Impact factor: 6.244

8.  Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.

Authors:  Nicolas Aide; Marjolaine Talbot; Christophe Fruchart; Gandhi Damaj; Charline Lasnon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-07       Impact factor: 9.236

9.  Spatial heterogeneity of oxygenation and haemodynamics in breast cancer resolved in vivo by conical multispectral optoacoustic mesoscopy.

Authors:  Jiao Li; Andrei Chekkoury; Jaya Prakash; Sarah Glasl; Paul Vetschera; Benno Koberstein-Schwarz; Ivan Olefir; Vipul Gujrati; Murad Omar; Vasilis Ntziachristos
Journal:  Light Sci Appl       Date:  2020-04-13       Impact factor: 17.782

10.  A study of radiomics parameters from dual-energy computed tomography images for lymph node metastasis evaluation in colorectal mucinous adenocarcinoma.

Authors:  Yingying Liu; Yafang Dou; Fang Lu; Lei Liu
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.